Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM
· Real-Time Price · USD
19.91
-0.02 (-0.10%)
At close: May 01, 2025, 3:59 PM
19.40
-2.56%
After-hours: May 01, 2025, 05:56 PM EDT
Beam Therapeutics Revenue
Beam Therapeutics reported an annual revenue of $63.52M, reflecting a -83.18% growth. For the quarter ending December 31, 2024, Beam Therapeutics generated $30.07M in revenue.
Revenue (ttm)
$63.52M
Revenue Growth
-83.18%
Price / Sales Ratio
32.14
Revenue / Employee
$131.51K
Employees
483
Market Cap
2B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 63.52M | -83.18% |
| Dec 31, 2023 | 377.71M | +520.01% |
| Dec 31, 2022 | 60.92M | +17.51% |
| Dec 31, 2021 | 51.84M | +215916.67% |
| Dec 31, 2020 | 24K | n/a |